KRAS-G12V, R and S expansion program (VRise Therapeutics)

N/A

Report date: 2025/01/26 18:38:14
NME

Base Information

Drug NameKRAS-G12V, R and S expansion program (VRise Therapeutics)
Drug Alias NameRAS Expansion Program (VRise Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVrise Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVrise Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A